Research Protocol
Volume 10 Issue 1 - 2021
Dual Users of Tobacco: Outcomes of Their Management in a TCC at a Multispecialty Hospital in India
Rakesh Gupta1*, Sameer Narake2 and Harsh Udawat3
1Honorary Consultant, Tobacco Treatment, Department of Deaddiction, Santokba Durlabhji Memorial Hospital and Medical Research Institute, Jaipur, India
2Statistician, Healis Sekhsaria Institute of Public Health, Navi Mumbai, Maharashtra, India
3Honorary Consultant, Gastroenterology and Alcohol Deaddiction, Departments of Gastroenterology and Deaddiction, Santokba Durlabhji Memorial Hospital and Medical Research Institute, Jaipur, Rajasthan, India
*Corresponding Author: Rakesh Gupta, FAIS, Honorary Consultant, Tobacco Treatment, Department of Deaddiction, Santokba Durlabhji Memorial Hospital and Medical Research Institute, Jaipur, India.
Received: October 27, 2020; Published: December 29, 2020


Background: The dual use of tobacco (smoked as well as smokeless tobacco products) is mostly to either circumvent ever-growing smoke-free environment or to obtain a higher dose of nicotine to satisfy its addiction.

Material and Methods: This prospective, non-randomized study of 109 current dual tobacco users over 30 months (September 2017 to February 2020) from a TCC in a multi-specialty tertiary care hospital has focused to observe and report a correlation of the outcomes of the tobacco dependence treatment with critical features in the process- setting up of the quit date, addiction to nicotine and follow-up up to 1 year.

Results: In this male dominated study (99.08%), 41 quitted successfully (36.7%; CI - 28.1, 46.0) while 43 failed to quit (39.4%; CI- 30.6, 48.8) and 26 relapsed (23.9%; CI- 16.6, 32.5). The sole determinant to stay abstinent totally was their ability to stay quit through the follow-up of over 6 months.

Conclusion: The new learning from this study on the dual users of tobacco in India is that to achieve a higher quit rate, there is need is to sustain follow-up for a longer duration among the successful quitters. Endorsing quitting over harms reduction, this study recommends a larger and elaborate multi-centre study in view of their smaller numbers vs. sole users of smoking or SLT.

Keywords: Tobacco; Dual Users; Outcomes; India


  1. Singh K., et al. “Social Determinants of Dual Tobacco Use in India: An analysis based on the two rounds of Global Adult Tobacco Survey”. Preventive Medicine Reports 18 (2020): 1-9.
  2. Frost-Pineda K., et al. “Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?” Nicotine and Tobacco Research 11 (2010): 1055-1067.
  3. Danielsson M., et al. “Alarming development of dual snus and cigarette usage among young Finnish males”. BMC Public Health 19 (2019):1249-1255.
  4. Reinberg S. “Some kids use tobacco, E cigarettes together, study finds”. Healthday Reporter. Medical Press (2015).
  5. Global Adult Survey Report: India 2016-17 Report. Tata Institute of Social Sciences (TISS), Mumbai and Ministry of Health and Family Welfare, Government of India”. Global Adult Tobacco Survey GATS 2 India 2016-17 (2018).
  6. Gupta PC., et al. “Profile of dual tobacco users in India: An analysis from Global Adult Tobacco Survey, 2009-10”. Indian Journal of Cancer 49 (2012): 393-400.
  7. Tomar S. “Snuff use and smoking in US Men”. American Journal of Preventive Medicine 3 (2002): 143-149.
  8. Tomar SL., et al. “Patterns of dual use of cigarettes and smokeless tobacco among US males: findings from national surveys”. Tobacco Control 19 (2010): 104-109.
  9. Messer K., et al. “Cigarette smoking cessation attempts among US smokers who also use smokeless tobacco”. Addictive Behaviors 51 (2015): 113-119.
  10. Zhu S-H., et al. “Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate Swedish results?” Tobacco Control 2 (2009): 82-87.
  11. Wetter DW., et al. “Concomitant use of cigarettes and smokeless tobacco: prevalence, correlates and predictors of tobacco cessation”. Preventive Medicine 6 (2002): 638-648.
  12. Fischer MT., et al. “Smokeless tobacco mortality risks: an analysis of two contemporary nationally representative longitudinal mortality studies”. Harm Reduction Journal 16 (2019): 27-36.
  13. Timberlake DS., et al. “A longitudinal study of smokeless tobacco use and mortality in the United States”. International Journal of Cancer 2 (2017): 264-270.
  14. Gupta R and Narake S. “Systems Approach in Tobacco Dependence Treatment through Hospitals”. Journal of Health Management4 (2018): 453-464.
  15. Gupta R., et al. “Proactive Telephonic Follow-up Calls by a Tobacco Cessation Clinic (TCC): Optimization for the Number of Calls”. Journal of Indian Dental Association (JIDA) 9 (2020): 12-18.
  16. Jhanjee S. “Putting tobacco harm reduction in perspective: is it a viable alternative?” Indian Journal of Medical Research 143 (2016): 25-29.
Citation: Rakesh Gupta., et al. “Dual Users of Tobacco: Outcomes of Their Management in a TCC at a Multispecialty Hospital in India”. EC Psychology and Psychiatry 10.1 (2021): 21-25.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 14, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.